Clinical Trial Update: Safety of Lopinavir/Ritonavir (Kaletra) in HIV/HCV Co-infected Subjects vs Baseline Liver Biopsy Metavir Score [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the safety of lopinavir/ritonavir in HIV/HCV co-infected patients, with safety outcomes referenced against baseline liver biopsy Metavi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis C

Drugs mentioned

• Kaletra (lopinavir)

Snippet

Sponsor: AbbVie (prior sponsor, Abbott) | Conditions: HIV Infection | Phase 4 | Status: COMPLETED